Gene therapy gets FDA approval -- and a $2 million price tag

The US Food and Drug Administration approved a treatment Friday for a genetic disease called spinal muscular atrophy that causes infants' muscles to waste away, potentially killing them before age 2.

from CNN.com - RSS Channel - Health https://cnn.it/2X2nSoY